Initial Treatment for Gastritis
The preferred initial treatment for gastritis is a 14-day quadruple therapy regimen containing a proton pump inhibitor, bismuth subsalicylate, tetracycline, and metronidazole, which has an eradication rate of 85%. 1
Diagnosis Before Treatment
Before initiating treatment, proper diagnosis is essential:
- Stop proton pump inhibitors (PPIs) for at least 2 weeks before testing to avoid false-negative results
- Use either urea breath test (UBT) or monoclonal antibody-based stool antigen test for diagnosis (sensitivity 95%, specificity 90%)
- If PPIs cannot be stopped, validated IgG serology can be performed as it's not affected by PPI use 1
Treatment Options
First-Line Treatment Regimens
Bismuth quadruple therapy (preferred) - 14 days:
- Proton pump inhibitor
- Bismuth subsalicylate
- Tetracycline
- Metronidazole
- Eradication rate: 85% 1
Concomitant non-bismuth quadruple therapy - 14 days:
- Proton pump inhibitor
- Amoxicillin
- Metronidazole
- Clarithromycin
- Eradication rate: 80% 1
Standard triple therapy - 14 days (for areas with low clarithromycin resistance <20%):
- Proton pump inhibitor
- Clarithromycin
- Amoxicillin
- Eradication rate: 85% 1
Important Treatment Considerations
- In areas with high clarithromycin resistance, bismuth-containing quadruple therapy is preferred 1
- Concomitant antacids should be given as needed for pain relief 2
- Follow-up testing should be performed at least 4 weeks after treatment completion to confirm bacterial eradication 1
Special Patient Populations
- Patients over 45 years with severe symptoms or any patients with alarm symptoms (anemia, weight loss, dysphagia, palpable mass, malabsorption) should be referred for endoscopy before treatment 1
- Younger patients (<45 years) without alarm symptoms can be managed in primary care with H. pylori testing and eradication 1
- For gastric ulcers, proton pump inhibitor therapy should be continued until complete healing is achieved 1
- For duodenal ulcers, proton pump inhibitor therapy should be continued until bacterial eradication is confirmed 1
Management of Treatment Failure
- If first-line therapy fails, use a different regimen than the initial treatment 1
- After two treatment failures, obtain antimicrobial susceptibility testing to guide further treatment 1
- For treatment-experienced patients with persistent H. pylori infection, "optimized" bismuth quadruple therapy for 14 days is preferred 1
Common Side Effects and Management
- Common side effects include diarrhea, skin rash, vomiting, nausea, metallic taste, and muscle/joint pains
- Probiotics may help reduce side effects, though evidence is limited 1
- Penicillin allergy testing should be considered in patients with a history of penicillin allergy but without anaphylaxis 1
Important Clinical Pitfalls
- Failing to stop PPIs before diagnostic testing, leading to false-negative results
- Using inadequate treatment duration (14 days is recommended for optimal eradication)
- Not confirming eradication after treatment completion
- Misdiagnosing chronic gastritis as the cause of long-standing upper abdominal complaints 3
- Not recognizing that PPIs alone are ineffective in eradicating H. pylori (eradication rate 0% at 6 months) 4